SOURCE: Theravance, Inc.

January 25, 2007 17:30 ET

Theravance to Report Fourth Quarter and Full Year 2006 Financial Results on February 8, 2007

SOUTH SAN FRANCISCO, CA -- (MARKET WIRE) -- January 25, 2007 -- Theravance, Inc. (NASDAQ: THRX) announced today that it will release financial results for the fourth quarter and full year ended December 31, 2006 after market close on Thursday, February 8, 2007.

An accompanying conference call will be held at 5:00 p.m. Eastern Standard Time. To participate in the live call by telephone, please dial 800-811-0667 from the U.S., or 913-981-4901 for international callers. Those interested in listening to the conference call live via the internet may do so by visiting the company's web site at To listen to the live call, please go to the web site 15 minutes prior to its start to register, download, and install any necessary audio software.

A replay of the conference call will be available on the company's web site for 30 days through March 10, 2007. An audio replay will also be available through 11:59 p.m. Eastern Standard Time on February 22, 2007 by dialing 888-203-1112 from the U.S., or 719-457-0820 for international callers, and entering confirmation code 5395479.

About Theravance

Theravance is a biopharmaceutical company with a pipeline of internally discovered product candidates. Theravance is focused on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections and gastrointestinal motility dysfunction. Of the five programs in development, two are in late stage -- its telavancin program focusing on treating serious Gram-positive bacterial infections with Astellas Pharma Inc. and the Beyond Advair collaboration with GlaxoSmithKline. By leveraging its proprietary insight of multivalency to drug discovery focused on validated targets, Theravance is pursuing a next generation drug discovery strategy designed to discover superior medicines in large markets. For more information, please visit the company's web site at

THERAVANCE®, the Theravance logo, and MEDICINES THAT MAKE A DIFFERENCE® are registered trademarks of Theravance, Inc.

Contact Information

  • Contact Information:

    Theravance, Inc.
    Allison Parker
    Director, Investor Relations
    Email Contact

    Theravance, Inc.
    David Brinkley
    Senior Vice President, Commercial Development
    Email Contact